Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2− Early Breast Cancer in the Real-World Setting

Karen Gambaro, Kahina Rachedi, Mark Basik [...]

Breast Cancer: Basic and Clinical Research

Retricted access

Review article

First published 2022-11

Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2− Early Breast Cancer

Farah Raheem, Henry Ofori, Lacey Simpson [...]

Annals of Pharmacotherapy

Open access

Research article

First published 2023

Rationale and trial design of NATALEE: a Phase III trial of adjuvant ribociclib + endocrine therapy versus endocrine therapy alone in patients with HR+/HER2− early breast cancer

Dennis J. Slamon, Peter A. Fasching, Sara Hurvitz [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024

Association Between Ki-67 Proliferative Index and Oncotype-Dx Recurrence Score in Hormone Receptor-Positive,HER2-Negative Early Breast Cancers. A Systematic Review of the Literature

Mehwish Mooghal, Muhammad Ali Akbar Khan, Mirza Rameez Samar [...]

Breast Cancer: Basic and Clinical Research

Open access

Research article

First published 2024

Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive,HER2−,high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study

Qingyuan Zhang, Kunwei Shen, Chuan-gui Song [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2021-4

The use of genomic tests in patients with breast cancer in Lombardy: a successful healthcare model

Giancarlo Pruneri, Carlo Alberto Tondini

Tumori Journal

Open access

Review article

First published 2025

Clinician’s guide: expert insights on the use of CDK4/6 inhibitors in patients with early breast cancer

Marya Hussain, Christine Brezden-Masley, Stephen Chia [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2022

Cost-effectiveness analysis of Oncotype DX from a Brazilian private medicine perspective: a GBECAM multicenter retrospective study

Leandro Jonata Carvalho Oliveira, Thais Baccili Cury Megid, Daniela Dornelles Rosa [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2023

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+,HER2−,node-positive,high-risk early breast cancer

Shani Paluch-Shimon, Patrick Neven, Jens Huober [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025

CanAssist Breast-based prognostication in low-intermediate estrogen receptor positive (ER 1%–20% ) early-stage breast cancer patients helps guide treatment decisions

Susmita Ghosh, Tejal Deepak Durgekar, Manvi Sunder [...]

Therapeutic Advances in Medical Oncology

Search results